The mean serum and CSF concentration of Parkin in our MS Japanese group were higher than values found in the Italian and Indian MS cohort (7, 8, 21, 22), suggesting that MS patients from different ethnicity and genetic backgrounds have altered immunopathogenesis (23). The gene discussed is PRKN; the disease is myeloid sarcoma.